Marlena (@PharmFox12) header
Marlena (@PharmFox12) profile picture

Marlena

@PharmFox12
 Orlando, FL
Joined June 2018
  • Tweets93
  • Following87
  • Followers53
@PharmD_intheED @chanceycarother @PharmFox12 @WinterHog @SydneyMcNeill15 @klbirrer @ORMCPharmRes @CaraSlaton
1
2
468
Another ORMC-Orlando Health PGY1 and PGY2 CC alum and current Orlando Health Critical Care clinician, @SydneyMcNeill15, presenting our Silver Snapshot Award winning research on VTE Prophylactic practices in Trauma, A Survey of PharmDs #SCCM2023
Image from Brandon Hobbs, PharmD, BCCCP, FCCM (@WinterHog)
5
2
15
1,788
ORMC-Orlando Health PGY1 & PGY2 CC Resident alum and current Cardiovascular Critical Care clinician, Chancey Carothers, delivering the SCCM Florida Chapter award winning research on Abrupt vs Weaning of HCT in septic shock #SCCM2023 #OrlandoHealth
Image from Brandon Hobbs, PharmD, BCCCP, FCCM (@WinterHog)
2
3
20
1,621
Thrombectomy is indicated for which of the following occlusions? #PharmICU #SCCM @SCCM_CPP
80%Large vessel occlusions
0%Small vessel occlusions
0%Only M1 & ICA occlusions
20%Lg & sm vessel occlusions
5 votes • Final results
84
What is the appropriate dosing for IV tPA for AIS? #PharmICU #SCCM @SCCM_CPP
0%90 mg IV push
0%0.5 mg/kg IV push
100%0.9 mg/kg (max 90 mg)
0%0.25 mg/kg (max 90 mg)
4 votes • Final results
76
Thrombectomy plus thrombolytic therapy should be considered the mainstay of treatment for patients with AIS. IV tPA plus thrombectomy may increase the incidence of successful reperfusion. #PharmICU #SCCM @SCCM_CPP
1
3
182
Anisa Sulaj will present: Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. bit.ly/3hpLPG9
58
Based on the PEACH trial, what can we conclude about the utility of ppx levetiracetam for seizure prevention in patients with non-traumatic ICH? #PharmICU #SCCM @SCCM_CPP
0%Levetiracetam effective
100%Possibly effective
0%Not effective
3 votes • Final results
70
Current guidelines recommend routine prophylactic antiseizure therapy to prevent epileptic seizures in the acute phase of non-traumatic ICH. #PharmICU #SCCM @SCCM_CPP
0%True
100%False
4 votes • Final results
65
Levetiracetam showed possible efficacy at preventing occurrence of seizures after non-traumatic ICH,but RCT is needed to answer whether seizure ppx improves outcomes. #PharmICU #SCCM @SCCM_CPP
2
128
Levetiracetam displayed safe ADE profile when utilized for seizure prevention after non-traumatic ICH with the most observed ADEs being HA and falls. #PharmICU #SCCM @SCCM_CPP
2
114
Austin Willett (@WillettPharmD) will present: Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a randomised, double-blind, placebo-controlled, phase 3 trial. bit.ly/3iXv59z
2
160
Which of the following secondary outcomes was found to be statistically significant? #PharmICU #SCCM @SCCM_CPP
0%Serious ICU adverse rxn
0%Length of hospital stay
0%Death at 90 days
0%Open label antipsychotics
0 votes • Final results
37
Which of the following is considered a limitation of the AID-ICU trial? #PharmICU #SCCM @SCCM_CPPITTI
100%Few pts w hypoactive type
0%Haloperidol dosing used
0%Study design
0%ITT analysis
2 votes • Final results
57
In ICU pts with delirium, use of haloperidol did not increase the number of days alive & out of hospital at 90 days. The mortality benefit observed indicates the need for more studies using doses of antipsychotics consistent with those used in practice. #PharmICU #SCCM @SCCM_CPP
1
4
212
Meghan Cook will present: Haloperidol for the Treatment of Delirium in ICU Patients. bit.ly/3HuudDL
52
Please join us for our monthly Spotlight on Pharmacy CPP Journal Club on 12/16 at 2 pm Eastern! Register at bit.ly/3uPkO1T: #PharmICU #SCCM
48
Thank you to all who came by our Showcase booth at the ASHP Midyear Meeting. We enjoyed getting to talk with you! If you have further questions please consider joining us for our PGY-2 Critical Care Open House on December 19th at 5:00 pm.
Image from ORMC Pharmacy Residency (@ORMCPharmRes)
8
3
4
Who’s at #ASHP22??? For any candidates interested in a PGY-1 or PGY-2 in Critical Care, come visit our Residency Showcase booth today from 1-4PM!!
1
3
5
How often do people receiving dexmedetomidine develop fever?
23%1 person in 500
22%1 person in 50
13%1 person in 15
41%Answers please
1,770 votes • Final results
5
11
32
Load more